MDK(SH:688079) Zheng Quan Shi Bao Wang·2025-12-10 13:13Core Viewpoint - The company Medike (688079) has approved a capital increase for its subsidiary, Zhejiang Medike Optical Semiconductor Co., Ltd., by introducing a strategic investor, which is expected to enhance its financial strength and core competitiveness [1][2] Group 1: Capital Increase Details - The strategic investor, Zhejiang Fuzhe Shaoxin Integrated Circuit Industry Fund Partnership (Limited Partnership), will invest 200 million yuan at a pre-investment valuation of 2.18 billion yuan, acquiring an 8.40% stake in the subsidiary [1] - After the capital increase, Medike's ownership in the optical semiconductor company will decrease to 82.44%, while the stake of the Service Trade Innovation Development Guidance Fund (Limited Partnership) will drop to 9.16% [1] Group 2: Financial Performance - The projected revenue for Medike Optical Semiconductor Co., Ltd. in 2024 is 313 million yuan, with a net loss of 42.47 million yuan; for the first three quarters of 2025, the revenue is expected to be 264 million yuan, with a net loss of 65.77 million yuan [1] Group 3: Strategic Implications - The capital increase is aimed at meeting the capital needs for the main business operations of Medike Optical Semiconductor and is expected to create synergistic effects by pooling various advantageous resources [2] - The agreement includes provisions for potential share buybacks, allowing Medike to repurchase shares from the investor and existing shareholders within four years under certain conditions [2]